Procter & Gamble Health Limited
₹5,148.35
INR-64.70(-1.24%)
As of November 14, 2024 10:00:00 AMAbout Procter & Gamble Health Limited
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.
RevenueLast 12 months
NA
+NA YoY
Total revenue generated from all business operations over the last 12 months
EBITDALast 12 months
NA
Earnings Before Interest, Taxes, Depreciation, and Amortization - a measure of company's operating performance
Price to Sales RatioTTM
7.29x
Compares a company's stock price to its revenues. Lower ratio might indicate an undervalued stock
Operating MarginLast 12 months
14.47
+-43.7% quarterly YoY
Operating income as a percentage of revenue, indicating operational efficiency
Market Cap
8392.32 CrINR
Total market value of the company's outstanding shares
Employees
1407
Total number of full-time employees worldwide
CEO
NA
Chief Executive Officer of the company